Remove 2004 Remove Documentation Remove Packaging
article thumbnail

Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing

European Pharmaceutical Review

Given that multiple work packages may often start or end together, or else take longer than others ( Figure 1 ), the introduction of new PAT requires assessment and planning by multiple departments. Any documentation, such as validation reports then helps with compliance and later regulatory submissions and requests.

article thumbnail

Medicare Part D for LTC Pharmacy: A Refresher

Integra X Files

Industry representatives spent many hours during 2004 discussing the needs of nursing home residents and the current standards of service. The document also requires plans to provide a transition period for non-formulary drugs to ensure beneficiaries have continuous access to required medications.

article thumbnail

Regulating decentralised manufacturing in the UK – a legal perspective

European Pharmaceutical Review

In the EU, the EU pharmaceutical package of reform 5 includes a proposed new Directive, 6 which will replace the current Medicines Directive (2001/83/EC). Master file the manufacturing dossier in which the main regulatory documents are collected and to which all subordinate sites refer. Under the Human Tissue Act 2004.